In the present study, although there was no significant change in the plasma concentration of sTREM2, the NAFLD rats presented not only a declining abundance of TREM1 in the plasma and hippocampus but also an increased expression of TREM2 in the hippocampus. Here, TREM2 is linked to metabolic dysfunction-associated steatotic liver disease.